Skip to main content
OpenTrials

Clinical trial condition

Advanced Malignancies

Explore clinical trials studying Advanced Malignancies. Study availability and eligibility vary by location and protocol.

59 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Advanced Malignancies trial results

Completed

A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies

NCT03241173

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
Locations
  • The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States
  • Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
View all 15 locations
View Trial Details
Completed

To Evaluate the Safety, and Pharmacokinetics of Parscaclisib in Participants With Normal Hepatic Function and Hepatic Impairment.

NCT04831944

Conditions
Advanced Malignancies
Locations
  • Inland Empire Liver Foundation Rialto, California, United States
  • Orange County Research Center Tustin, California, United States
  • Clinical Pharmacology of Miami Hialeah, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
View Trial Details
Completed

A Study of PLX2853 in Advanced Malignancies.

NCT03297424

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +36 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • Sylvester Comprehensive Cancer Center / University of Miami Miller School of Medicine Miami, Florida, United States
  • Columbia University Medical Center New York, United States
  • South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States
View Trial Details
Completed

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of Recombinant Human Anti-cluster Differentiation Antigen 47 (CD47) Monoclonal Antibody Injection (IBI188) in Patients With Advanced Malignant Tumors and Lymphomas

NCT03763149

Conditions
Advanced Malignancies
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • Thomas Jefferson Univerity Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • START (South Texas Accelerated Research Therapeutics, LLC) San Antonio, Texas, United States
View Trial Details
Completed

ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) Participants

NCT02737501

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +17 more
Locations
  • USOR - Arizona Oncology Associates - Sedona Sedona, Arizona, United States
  • Kaiser Permanente Bellflower Medical Offices Bellflower, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Rocky Mountain Cancer Centers - Boulder Boulder, Colorado, United States
View all 91 locations
View Trial Details
Completed

A Study of INCAGN01876 in Participants With Advanced or Metastatic Solid Tumors

NCT02697591

Conditions
Adenocarcinoma, Advanced Malignancies, Bronchial Neoplasms, +36 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • Yale University New Haven, Connecticut, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions